Long-term analysis of quality of life in glioma patients
Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients and Setting Up a Large-scale, Prospective Database for Glioma Patients Treated in UZ Leuven
This study is trying to see how living with glioma, a type of brain tumor, affects patients' quality of life over time, using a detailed questionnaire to gather information.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 750 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven, Vlaams-Brabant) |
| Trial ID | NCT03849430 on ClinicalTrials.gov |
What this trial studies
This study aims to conduct a large-scale, prospective analysis of health-related quality of life (HRQOL) in patients diagnosed with glioma, a common type of brain tumor. It will establish a comprehensive database that includes patient characteristics, tumor information, treatment strategies, and follow-up data. The HRQOL will be assessed using the EQ-5D questionnaire, which evaluates various health dimensions such as mobility, self-care, and psychological well-being. The study will track HRQOL over time, focusing on both low-grade and high-grade glioma patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed and treated for either low-grade or high-grade glioma.
Not a fit: Patients who have not been diagnosed with glioma or those under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the quality of life for glioma patients, potentially guiding future treatment approaches.
How similar studies have performed: Other studies have successfully utilized similar methodologies to assess quality of life in cancer patients, indicating that this approach is both valid and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * age ≥ 18 years * patients diagnosed and treated for a high- or low grade glioma * treatment in UZ Leuven
Where this trial is running
Leuven, Vlaams-Brabant
- UZ Leuven — Leuven, Vlaams-Brabant, Belgium (Recruiting)
Study contacts
- Principal investigator: Steven De Vleeschouwer, MD Phd — UZ Leuven
- Study coordinator: Steven De Vleeschouwer, MD Phd
- Email: steven.devleeschouwer@uzleuven.be
- Phone: +3216344290
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.